USPTO serial 97607448
MORPHOCEUTICALS
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jan 21, 2025
- Examiner
- HAHN, AMY
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with MORPHOCEUTICALS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Norm J. Rich
Norm J. Rich Foley & Lardner LLP3000 K Street, N.W., Suite 600Washington, DC 20007-5109United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Stem cells for research or scientific purposes; chemical preparations for use in scientific research, other than medical or veterinary use, all for use in relation to tissue, organ and limb repair and regeneration therapy; diagnostic preparations for scientific or research use other than for medical use; media for cell culture for use in non-medical research laboratories; reagents for medical research use; reagents for scientific or medical research use | ACTIVE | — |
| 005 | Pharmaceutical preparations for use in tissue repair and organ and limb repair and regeneration and for use in the regeneration of stem cells; pharmaceutical preparations containing stem cells for use in tissue repair and organ and limb repair and regeneration; stem cells for medical purposes; stem cells for veterinary purposes; surgical implants grown from stem cells; surgical implants grown from stem cells comprising living tissues; cells for medical or clinical use | ACTIVE | — |
| 009 | Downloadable computer software for use in database management in the field of regenerative medicine; downloadable computer programs for use in database management for assisting in machine learning in the field of regenerative medicine; computer hardware | ACTIVE | — |
| 010 | Surgical apparatus and instruments; medical apparatus and instruments for use in surgical procedures for tissue repair and organ and limb repair and regeneration; mechanically and surgically implanted medical apparatus comprised of artificial material and natural, non-living materials for use in the healing of truncated limbs and for use in tissue repair and organ and limb repair and regeneration and for the regeneration of stem cells; artificial limbs; limb compression instruments, namely, therapeutic compression wraps; hosiery, namely, prosthetic sheaths for limbs; prosthetic sleeves for limbs; prosthetic socks for limbs | ACTIVE | — |
| 035 | Compilation and systemization of information into computer databases; data processing services in the field of healthcare and medical research | ACTIVE | — |
| 042 | Scientific and technological services, namely, research and design in the fields of regenerative medicine, tissue repair, organ and limb repair and regeneration, and the regeneration of stem cells; industrial analysis and research services in the field of regenerative medicine; design and development of computer software and hardware; providing online, non-downloadable software for use in database management in the field of regenerative medicine; biomedical research services; data mining services; bioinformatics services, namely, biological data analysis for scientific research purposes; biological, medical and clinical data analysis, namely, compiling data for research purposes in the field of regenerative medicine; consultancy regarding generation of biological, medical and clinical data; computational analysis of scientific and medical data; stem cell research services; biological research and medical research; clinical research in the field of regenerative medicine; veterinary research services; scientific research for medical purposes in the field of regenerative medicine; medical research laboratory services; providing medical and scientific research information in the field of stem cells, tissue, limb and organ regeneration and clinical trials; provision of information and data relating to medical and veterinary research; compiling statistical data for medical, veterinary and clinical research purposes; all of the aforesaid limited to use in relation to tissue, organ and limb repair and regeneration therapy | ACTIVE | — |
| 044 | Medical services; veterinary services; healthcare services, namely, health care services in the field of regenerative medicine; medical services relating to the removal, treatment and processing of stem cells; medical and veterinary services relating to human and animal tissue, limb and organ regeneration; stem cell therapy services; stem cell storage services; stem cell bank services; fitting of artificial limbs, prosthetic devices and prostheses; fitting of artificial limbs; providing medical and medical clinical data analytics and bioinformatics services; providing health care data analytics and bioinformatics services | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Morphoceuticals, Inc.
- Other trademarks owned by Morphoceuticals, Inc.
- Other trademarks owned by Morphoceuticals, Inc.
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 035
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named MORPHOCEUTICALS
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jan 21, 2025 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jan 21, 2025 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Dec 3, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Dec 3, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 27, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Nov 8, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 6, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 6, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 6, 2024 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Sep 6, 2024 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Aug 22, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 22, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 22, 2024 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Jan 19, 2024 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Jan 19, 2024 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Jan 19, 2024 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Jan 19, 2024 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jan 19, 2024 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jan 19, 2024 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jan 19, 2024 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jan 12, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 11, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 11, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 8, 2024 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jan 8, 2024 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 8, 2024 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jan 8, 2024 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Jan 8, 2024 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Oct 9, 2023 | XELG | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | — |
| Oct 9, 2023 | XELR | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | — |
| Jul 12, 2023 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 12, 2023 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 12, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 10, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 12, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Sep 29, 2022 | NWAP | NEW APPLICATION ENTERED | — |